Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|December 3, 2014
A comparison of the metabolism of midazolam in C57BL/6J and hepatic reductase null (HRN) miceAidan Grimsley, Alison Foster, Richard Gallagher, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 3, 2026
Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experienceJohn L Berk, Kevin J Carroll, Jorge Mejia Baranda, et al.
NPJ Parkinson'S Disease|June 14, 2025
Cutaneous nerve fiber pathology and function in Parkinson's disease and atypical parkinsonism - a cohort studyMattias Andréasson, Wojciech Paslawski, Astrid Juhl Terkelsen, et al.
Journal of Internal Medicine|September 17, 2025
Sixty years of experience with hereditary transthyretin amyloidosis: Insights from the Swedish transthyretin amyloidosis registryLotta Stenberg, Björn Pilebro, Intissar Anan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 31, 2012
Pharmacokinetics and metabolism of midazolam in chimeric mice with humanised liversKristin Samuelsson, Kathryn Pickup, Sunil Sarda, et al.
Scientific Reports|February 15, 2018
The Fate of a Hapten - From the Skin to Modification of Macrophage Migration Inhibitory Factor (MIF) in Lymph NodesIsabella Karlsson, Kristin Samuelsson, Carl Simonsson, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 15, 2014
Troglitazone metabolism and transporter effects in chimeric mice: a comparison between chimeric humanized and chimeric murinized FRG miceKristin Samuelsson, Kathryn Pickup, Sunil Sarda, et al.
The Lancet Regional Health. Europe|January 6, 2025
Association between cardiometabolic diseases and the risk and progression of motor neuron diseases in Sweden: a population-based case-control studyCharilaos Chourpiliadis, Anikó Lovik, Christina Seitz, et al.
Journal of Neurology|June 15, 2024
Lifestyle and medical conditions in relation to ALS risk and progression-an introduction to the Swedish ALSrisc StudyCharilaos Chourpiliadis, Christina Seitz, Anikó Lovik, et al.
Frontiers in Immunology|December 11, 2023
Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assayIvan Kmezic, Rasmus Gustafsson, Katharina Fink, et al.
Pageof 5